William R. Swindell

The paper evaluates the DrugAge database, finding poor reporting quality and inconsistent effect sizes in anti-aging preclinical studies across species.

This study identifies VGLL3 as a key driver of preeclampsia by linking it to placental, vascular, and immune defects, showing its therapeutic potential through genetic and pharmacological inhibition.

This study identifies SIX1 as a driver of dermal fibrosis in systemic sclerosis by linking its upregulation to adipocyte dysfunction and fibrotic gene expression.